Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-04-02 | Amended | $300,000 | $200,000 | Equity Only | 06b | SEC link |
| 2023-10-11 | New | $100,000 | $100,000 | Equity Only | 06b | SEC link |
| 2022-09-29 | Amended | $400,000 | $300,000 | Equity Only | 06b | SEC link |
| 2021-06-02 | New | $100,000 | $100,000 | Equity Only | 06b | SEC link |
| 2020-10-07 | New | $100,000 | $100,000 | Equity Only | 06b | SEC link |
| 2017-11-03 | New | $100,000 | $100,000 | Equity Only | 06b | SEC link |
| 2013-05-20 | New | $120,000 | $120,000 | Equity Only | 06 | SEC link |
| Name | Role |
|---|---|
| John F. Schmedtje | Executive |
| John F. Schmedtje, J.R | Director, Executive |
| John Schmedtje, Jr. | Director, Executive |